Zura Bio (ZURA) Assets Average (2022 - 2026)

Zura Bio's Assets Average history runs 5 years deep, the most recent figure standing at $171.3 million for Q1 2026.

• On a quarterly basis, Assets Average fell 2.68% year-over-year to $171.3 million in Q1 2026; TTM through Mar 2026 was $171.3 million, a 2.68% decrease from a year earlier, with the FY2025 full-year figure at $146.7 million, up 4.67% from the prior year.
• Assets Average grew to $171.3 million in Q1 2026 per ZURA's latest filing, from $128.9 million in the prior quarter.
• Across five years, Assets Average topped out at $189.3 million in Q3 2024 and bottomed at $24.8 million in Q1 2023.
• The 5-year median for Assets Average is $140.1 million (2022), against an average of $130.0 million.
• Across the five-year window, Assets Average plunged 82.32% in 2023 and jumped 285.37% in 2024, its largest moves.
• Year by year, Assets Average stood at $72.9 million in 2022, then jumped by 40.96% to $102.7 million in 2023, then jumped by 79.43% to $184.3 million in 2024, then slumped by 30.04% to $128.9 million in 2025, then surged by 32.85% to $171.3 million in 2026.
• Per Business Quant, the three latest ZURA Assets Average figures stand at $171.3 million (Q1 2026), $128.9 million (Q4 2025), and $150.9 million (Q3 2025).